A Nonimmunosuppressant Approach on Asia Psoriasis Subjects: 5-Year Followup and 11-Year Data Analysis

Table 3

Immunosuppressants modalities in China and Singapore patients with psoriasis.

Immunosuppressants modalities in China and Singapore patients with psoriasis	%
Topical
Corticosteroids	98.7%
Calcipotriol	30.2%
Retinoid	11.4%
Tacrolimus	3.8%
Systemic
Systemic glucocorticoid	46.6%
UVB or PUVA	21.5%
Methotrexate	15.7%
Cyclosporine	5.2%
Azathioprine	0.2%
Hydroxyurea	0.2%
Herbal decoction
Glycyrrhiza (Gan Cao), Licorice [13–15]	71.5%
Lonicera (Jin Yin Hua), Honeysuckle	71.5%
Dictamnus (Bai Xian Pi), Burning Bush [16]	71.5%
Cryptotympana (Chan Tui), Cicada Slough	71.5%
Tripterygium (Lei Gong Teng), Threewingnut [17–20]	14.5%
Sophora (Ku Shen), Flavescent Sophora [15, 21, 22]	62.4%
Prunella (Xia Ku Cao), Self Heal [23]	71.5%
Curcuma (Jiang Huang, Yu Jin), Turmeric [24–27]	71.5%
Bupleurum (Chai Hu), Thorowax [28–30]	23.0%
Cordyceps sinensis (Dong Chong Xia Cao) [31, 32]	35.4%